exploration of different drug administration scenarios. It can provide valuable support for optimizing dose and schedule and allows the efficient investigation of drug distribution at a whole-body scale. This approach promises to enhance the personalization and effectiveness of cancer therapies, reduce research time and costs, and significantly advance the development of mRNA-based BiTEs for cancer treatment.
No takes yet. Share an insight, caveat, or question.
Fiandaca et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: